Anika Therapeutics, Inc. Operating Lease, Liability, Current
Anika Therapeutics, Inc. (ANIK) had Operating Lease, Liability, Current of $1.94 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-07-29
- 2026-06-30: Operating Lease, Liability, Current $1.94M.
- 2026-03-31: Operating Lease, Liability, Current $1.94M.
- 2025-12-31: Operating Lease, Liability, Current $2.05M.
- 2025-09-30: Operating Lease, Liability, Current $1.73M.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.94M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $1.94M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $2.05M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $1.73M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.81M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $1.87M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $1.92M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $2.29M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $2.29M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.13M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.83M 10-K · filed 2025-03-17 | $2.13M 10-Q · filed 2024-05-08 |
| 2020-09-30 | $1.46M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.48M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $1.48M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $1.14M 10-Q · filed 2020-11-05 | |
| 2019-09-30 | $1.11M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $1.10M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $1.07M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |